Make a donation today to help support amazing cancer researchers like Dr. Lumati! bit.ly/3UXJs0X
This #WorldCancerResearchDay, we can make more breakthroughs, more discoveries, and more hope possible for people facing cancer. @JulietOkoroh
3
7
1,161
Elizabeth A. Mittendorf, MD, PhD, MHCM, FASCO retweeted
Advance the science of oncology. As a JCO Journals reviewer, you can sharpen your own research skills while protecting the quality of cancer research.
Earn CME credits and FASCO™ points. Learn more and become a reviewer today: bit.ly/3Tyvdz4#PeerReviewWeek
2
2
1,963
Elizabeth A. Mittendorf, MD, PhD, MHCM, FASCO retweeted
⏳ Time is running out! Applications for the @ConquerCancerFd IDEA program close on Sept 30, 2026. Don't miss out on mentorship, attendance at the #ASCO27, and 3 years of ASCO membership.
Submit your application today: bit.ly/4hr30Dq
1
3
3
2,664
Elizabeth A. Mittendorf, MD, PhD, MHCM, FASCO retweeted
Upcoming Medicaid work requirements starting in 2027 could impact coverage and care delivery for patients with cancer. We break down what these policy changes mean and how we are working to protect patient access to care. Learn more: bit.ly/46rAJGG#ASCOAdvocacy
1
12
15
4,554
Elizabeth A. Mittendorf, MD, PhD, MHCM, FASCO retweeted
1 in 5 people worldwide will face a cancer diagnosis. Because cancer affects families across the globe, the science to conquer it must be global, too. 🌍
Read our latest blog post to learn how supporting research across borders drives tomorrow's breakthroughs: bit.ly/4A0Toqw
2
6
571
Elizabeth A. Mittendorf, MD, PhD, MHCM, FASCO retweeted
Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction this quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO.
Learn more about FASCO distinction: bit.ly/4ftRmp5
6
40
85
250,603
Elizabeth A. Mittendorf, MD, PhD, MHCM, FASCO retweeted
Expand your network, collaborate with regional peers, & develop practical leadership skills in our LDP: Asia Pacific program.
Review eligibility requirements & apply for the 2027 program by August 17, 2026: bit.ly/3RcmX6C
6
10
2,051
Elizabeth A. Mittendorf, MD, PhD, MHCM, FASCO retweeted
Ready to swap the standard #MedEd textbook for next-gen leadership? The 2027-28 ASCO LDP: Education Scholars is looking for its next cohort. This program is about building a community, learning leadership skills, & advancing medical education.
Apply: bit.ly/4ye91de
6
13
3,218
Elizabeth A. Mittendorf, MD, PhD, MHCM, FASCO retweeted
2027 Conquer Cancer funding opportunities are officially open! From early-career to advanced clinical research, @ConquerCancerFd has funding opportunities at every career stage.
Learn more and apply today: bit.ly/4vmPlRT#ResearchConquersCancer
8
14
2,034
Elizabeth A. Mittendorf, MD, PhD, MHCM, FASCO retweeted
As a previous participant, I look back on this experience with real gratitude.
It was a warm, inspiring, and meaningful journey. I felt welcomed, supported, and encouraged to grow.
What stayed with me most was the sense of connection and belonging.
I am truly grateful to have been part of it. @ASCO@ASCOPres
Ready to guide the future of oncology? Applications are open for our 2027-28 ASCO Leadership Development Program (LDP)! Transform into a next-gen leader through a 1-year immersive curriculum w/ mentorship, expert training, & a great group of peers: bit.ly/44KGTAL
1
8
16
1,461
Elizabeth A. Mittendorf, MD, PhD, MHCM, FASCO retweeted
Prior authorization delays harm people w cancer. The #SeniorsAct, is a bipartisan bill that would help #FixPriorAuth in Medicare Advantage and improve pt care. Congress needs to act NOW.
Tell your lawmakers to pass the Seniors Act: bit.ly/4vcCrWo#ASCOAdvocacy
13
23
4,923
Elizabeth A. Mittendorf, MD, PhD, MHCM, FASCO retweeted
We honor the memory of Dr. Maura L. Gillison, a 2021 ASCO Karnofsky Award recipient. Her landmark research establishing the link between HPV & oral cancer fundamentally changed modern oncology.
Read more about her legacy: bit.ly/4wc6Kgz
7
27
112
27,954
Elizabeth A. Mittendorf, MD, PhD, MHCM, FASCO retweeted
Thanks to all who attended and contributed to @ASCO Breakthrough #ascobt26 in Singapore this past week. Looking forward to seeing you here again next year - June 24-27, 2027. @CliffordHudis@ASCOPres
2
13
38
4,954
Elizabeth A. Mittendorf, MD, PhD, MHCM, FASCO retweeted
Research presented at #ASCOBT26 evaluated the clinical performance and feasibility of a multi-cancer early detection blood test in a real-world cohort across six Asian countries. @julian_hong explains in this Science in Seconds.
Read the abstract: bit.ly/4eDpyOF
4
9
2,252
Elizabeth A. Mittendorf, MD, PhD, MHCM, FASCO retweeted
Thank you to the National Cancer Center of Singapore @nccsingapore for hosting the @asco Asia Pacific Regional Council and International Clinical Research Scholars meetings this week! #ASCOBT26@RebeccaDSing@ASCOPres
1
10
37
1,136
Elizabeth A. Mittendorf, MD, PhD, MHCM, FASCO retweeted
Good morning from Singapore! ☀️ We’re so excited to be here kicking off Day 1 of #ASCOBT26! Today’s schedule is packed with groundbreaking scientific sessions, high-impact networking, and cultural experiences.
View the full program here: bit.ly/43sGlio
8
17
1,954
Elizabeth A. Mittendorf, MD, PhD, MHCM, FASCO retweeted
The full abstracts for 2026 ASCO Breakthrough are now available! Browse the novel research and emerging therapies that are shaping the future of cancer care. View the full abstracts here: bit.ly/44u11qB@SSO_Singapore